Results 201 to 210 of about 268,545 (217)

Medroxyprogesterone Acetate

2011
openaire   +1 more source

Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate

Fertility and Sterility, 2006
Barcey T Levy, Maryfran Sowers
exaly  

Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

Contraception, 2014
Carolyn Westhoff, Katharine O'Connell White, Anitra Beasley   +2 more
exaly  

Implanon�� versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis ��� a pilot study

Contraception, 2009
Christine Kurz, Katharina Walch, Elisabeth Pernicka   +2 more
exaly  

Bone mineral density in adolescent females using depot medroxyprogesterone acetate

Journal of Pediatric and Adolescent Gynecology, 2004
Eduardo Lara-Torre, S Paige Hertweck
exaly  

Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy

Fertility and Sterility, 2008
Kavita Nanda, Eliana Amaral, Luis Bahamondes   +2 more
exaly  

Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi

Contraception, 2019
Yasaman Zia, Jennifer Tang
exaly  

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results

Fertility and Sterility, 2003
James H Pickar
exaly  

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception

American Journal of Obstetrics and Gynecology, 2002
Ian Reid, Helen E. Roberts
exaly  

Genotoxic potential of medroxyprogesterone acetate in cultured human peripheral blood lymphocytes

Life Sciences, 2006
Mohammad Afzal, Yasir Hasan Siddique, Tanveer Beg   +2 more
exaly